-
-
-
-
-
-
-
Mirum Pharmaceuticals secures $68.5 million private placement with TCGX
-
-
-
-
-
-
-
Leerink Partners: 'MIRM’s Bluejay Deal Nice External Recognition of HDV Value; Positive for VIR'
-
-
-
-
-
-
-
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Mirum Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
-
-
-
-
-
-
-
Mirum Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
-
-
-
-
-
-
-
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

